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1INTRODUCTION
Hypertension (HTN) is defined as a repeatedly elevated
blood pressure (BP) exceeding a systolic blood pressure (SBP)
over 140 mmHg and/or a diastolic blood pressure (DBP) over
90 mmHg [1]. It is clear that HTN has become a worldwide
epidemic and an important risk factor of cardiovascular dis-
ease (CVD), which might cause fatal results in an individual
such as stroke, myocardial infarction, ischemic heart disease,
kidney disease, and peripheral vascular disease [1-4]. Revised
reports have been published every four or five years since the
Joint National Committee (JNC) on Prevention, Detection,
OBJECTIVES: The aim of this study was to investigate the effect of changes in cardiovascular disease (CVD)
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exercisers (37.6%) showed a slower progression rate than continuous smokers (49.5%) and continuous
drinkers (50.9%). In women, those who participated in regular exercise (22.6%) had a lower rate of progres-
sion than continuous non-exercisers (36.1%). According to the results of the Cox proportional hazard model,
improvements in smoking (hazard ratio [HR], 0.756), drinking (HR, 0.669), regular exercise (HR, 0.653),
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Evaluation, and Treatment of High Blood Pressure was first
established in 1977 [5]. In the recent JNC-7 report, a new cate-
gory known as prehypertension (PreHTN) was added. In this
category, the normal and high-normal BP of the JNC-6 criteria
are combined because even normal BP (SBP 120 to 129 mmHg
or DBP 80 to 84 mmHg) are potentially related to future CVD.
Several studies have investigated the short-term and long-term
progression rates from the non-hypertensive category to HTN
[6-12]. According to the Framingham Heart Study, at the age
of 55 yr, prehypertensive people had a two times higher risk
of progression to HTN than normotensive people [8]. Many
studies have suggested that lifestyle modifications might help
people to manage HTN [6, 9, 10, 13]. Researchers have been
interested in behavioral changes such as exercise, a healthy
diet, smoking cessation, etc. For example, a follow-up of the
data from the British Health and Lifestyle Surveys for 7 yr
showed that the relative risk (RR) (95% confidence intervals,
CI) of subjects who were overweight at follow-up but not at
baseline was 1.65 (1.33-2.14) and that the RR of subjects who
were overweight at baseline but not at follow-up was 0.58
(0.34-1.01) compared with those who were not overweight
at baseline or follow-up. Those who were smokers at follow-
up had a higher risk (RR, 95% CI: 1.12, 0.94-1.34) of HTN
than those who were non-smokers at baseline or follow-up
[9]. However, there have been few studies on the association
between CVD risk factors and the progression of HTN among
people with PreHTN in Korea. The purpose of this study was
thus to examine factors influencing progression using a pro-
spective cohort dataset, the Korean Cancer Prevention Study
(KCPS) from the National Health Insurance Corporation
(NHIC). 
SUBJECTS AND METHODS
Study population
NHIC provides a national health insurance program for
government employees, private school teachers and their
dependents. The NHIC data include the KCPS data from
1,329,525 Koreans between the ages of 30 and 95 yr who
underwent biennial medical evaluations. A total of 784,870
(59.0%) were enrolled in 1992, 367,903 (27.7%) in 1993,
98,417 (7.4%) in 1994, and 78,335 (5.9%) in 1995. A more
detailed description of the subjects can be found elsewhere
[14, 15]. In the present study, after randomly selecting 30%
of the subjects from the KCPS data, various exclusion pro-
cesses were carried out (Figure 1). The baseline data were
collected in 1994 and 1996. The data from participants were
examined at baseline and at follow-up health examinations
in 1998, 2000, 2002, and 2004. The study included exami-
nees who underwent the biennial health examination at least
once or more over the period of 8 yr. Participants were exclud-
ed if they had PreHTN or HTN in 1992. The final sample con-
sisted of 16,299 subjects with PreHTN at baseline (1994-1996)
who were followed every other year until 2004. The study
protocol was approved by the Yonsei University College of
Medicine ethical committee.
BP measurements
The BP of participants was measured by registered nurses
or trained technicians using a standard mercury sphygmo-
manometer or an automatic manometer. We used the mean
BP of 1994 and 1996 to minimize misclassification error. The
measured BP was classified as optimal (SBP <120 mmHg and
Figure 1. Data cleaning process for the study population. 
BMI, body mass index; SBP, systolic blood pressure; HTN, hypertension; DM, diabetes mellitus; DBP, diastolic blood pressure; FSG,
fasting serum glucose; TC, total cholesterol.
KCPS data from NHIC
(n=1,329,525, 
’92~’95, ’04)
n=226,768
n=192,880
n=56,327
n=50,902
n=16,299
∙Subjects including BMI and SBP at baseline 
∙Subjects without pasthistory of HTN or DM at baseline
∙30% random sampling
∙Those who enrolled newly from 1993 to 1995 were excluded (n=10,802)
∙Subjects aged 55 or more were excluded (n=23,086)
∙Subjects having prehypertension or hypertension in 1992 were excluded (n=136,553)
∙Subjects not having information of SBP, DBP, FSG, BMI, TC at baseline (1994-1996) were excluded (n=2,335)
∙Subjects not having any BP neasures from 1998 to 2004 were excluded (n=3,090)
∙Subjects having optimal BP and hypertension at baseline (1994-1996)
∙were excluded (n=34,603)
DBP <80 mmHg), normal (SBP 120 to 129 mmHg or DBP
80 to 84 mmHg), high-normal (SBP 130-139 mmHg or DBP
85 to 89 mmHg), or HTN (SBP ≥140 mmHg or DBP ≥90
mmHg) based on JNC-6 criteria.
Other measurements
Subjects were asked about their health behaviors and un-
derwent biochemical measurements in each biennial health
examination from 1992 to 2004. The health behavior charac-
teristics included smoking, drinking, regular exercise and their
family history of CVD-related diseases. Baseline data such as
age and a family history of CVDs were based on the records
from 1992. For smoking habits, the question asked was how
many cigarettes he/she smoked. The respondents had the
option of recording their current smoking status as never-
smoker, ex-smoker or current smoker. Subjects were asked
about their smoking habit status at each assessment to deter-
mine changes in smoking status. For drinking habits, the question
asked was what are his/her drinking habits. The options were
either ‘‘don’t drink,’’ ‘‘drink sometimes’’ or ‘‘drink often’’.
Subjects were categorized into either non-drinker or current
drinker (drinking sometimes and drinking often). Subjects
were also asked whether they had changed their drinking sta-
tus at the subsequent measurements. For regular exercise,
the question asked was whether he/she was involved in regu-
lar exercise. The respondents replied either ‘‘yes’’ or ‘‘no’’ to
the question. Subjects were classified into either those taking
regular exercise or those not doing regular exercise. The infor-
mation on smoking, drinking, and regular exercise at baseline
was either from the data recorded in 1994 if available, or in
1996. For the biochemical measurements, the body mass in-
dex (BMI), serum glucose and total cholesterol were mea-
sured after fasting. The mean value of the 1994 and 1996
measurements for BMI, fasting serum glucose (FSG), and total
serum cholesterol (TC) was used as the baseline. Changes in
health habits and co-morbidity information were defined as
any change between the data from 1994 or 1996 and the last
follow-up data from 1998, 2000, 2002, and 2004. 
Statistical methods
The t-test and c2-test were used to investigate the baseline
characteristics of the study population according to the base-
line BP. To assess the relationship between changes in CVD
risk factors and progression to HTN, the log-rank test was
performed. HRs and 95% CI were obtained by the Cox pro-
portional hazard model to determine the impact of changes in
CVD risk factors on progression to HTN. All statistical analy-
ses were conducted using SAS version 9.1.3 (SAS Institute
Inc., Cary, NC, USA). 
RESULTS
Baseline characteristics of the study population
according to baseline blood pressure
Table 1 shows the general characteristics of the study pop-
ulation according to baseline BP. The two groups (normal BP,
and high-normal BP) differed significantly in all characteris-
tics, except for the family history of CVD. The mean age was
38.6 yr for the normal BP group, and 39.8 yr for the high-nor-
mal BP group, respectively (p<0.0001). The high-normal group
showed a significantly higher percentage of smoking, alcohol
drinking and regular physical activity than the normal group.
The high-normal group had an elevated mean SBP, DBP, FSG,
and TC compared with the normal group (p<0.0001).
Association between changes in cardiovascular 
disease risk factors and progression from 
prehypertension to hypertension 
Tables 2, 3 summarize the results regarding the association
between the changes in CVD risk factors and the progression
rate in men and women. In men, the ex-smoker group (42.9%)
showed a slower rate of progression compared to the contin-
uous smoker group (49.5%) and the non-smoker group at base-
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*p-value by t-test or c2 test; �Age and family history in 1992 presented
because the data included individuals who participated in the health exam
in 1992 from the KCPS data.
Baseline blood pressure
Normal High-normal
(n=12,401) (n=3,898)
Characteristics p-value*
Table 1. Baseline characteristics of the study population accord-
ing to baseline blood pressure
Baseline (1994-1996)
Age�(yr), mean±s.d 38.6±6.5 39.8±6.8 <0.0001 
Gender
Men 77.9 83.4 <0.0001
Women 22.1 16.6
Body mass index (kg/m2) 22.9±2.4 23.4±2.5 <0.0001 
Current smoking (yes), % 46.9 48.0 <0.0001 
Alcohol drinking (yes), %  67.0 70.6 <0.0001 
Regular exercise (yes), % 25.1 27.7 0.0012 
Family history, %
Hypertension, stroke, heart disease 14.8 15.0 0.7670
Diabetes mellitus 7.6 6.7 0.0934
Systolic blood pressure (mmHg) 119.5±4.5 126.4±5.7 <0.0001 
Diastolic blood pressure (mmHg) 78.0±3.6 83.4±3.6 <0.0001 
Fasting serum glucose (mg/dL) 89.4±15.6 91.0±17.4 <0.0001 
Total serum cholesterol (mg/dL) 187.3±31.1 189.5±31.2 <0.0001 
line and the current smoker group at follow-up (51.0%). The
progression rate in the continuously drinking group was found
to be 50.9%, whereas that of the sober group stood at 37.5%;
the rate in the non-drinking group at baseline and the drink-
ing group at follow-up was 39.1%. Those participating in regu-
lar exercise had a slower rate of progression (37.6%) than that
in those who did not take regular exercise (49.6%) and that
in regular exercisers at baseline and non-regular exercisers at
follow-up (49.3%). The consistently obese group showed a
progression rate of 58.2% while the group in which weight
fluctuated (normal weight to overweight and vice versa) demon-
strated a 45.0% progression rate, resulting in a 13.2% differ-
ence. In terms of FSG measurements, the group with consis-
tently normal FSG showed the lowest progression rate (47.3%).
Unlike other CVD risk factors, the group with high FSG at
baseline and normal FSG at follow-up (55.3%) and the group
with normal FSG at baseline and high FSG at follow-up (52.1
%) had a slower rate of progression than the consistently high
FSG group (51.2%). In terms of TC measurements, the group
with improvements in TC demonstrated lower progression
rates than the consistently high TC group (Table 2). In women,
smoking was excluded from the analyses due to the extreme-
ly low current smoking rate. The progression rate in the con-
tinuously drinking group was 38.7%, whereas that of the sober
4
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Total no.Changes in CVD risk factors No. of HTN (%) No. of censored p-value*
Table 2. Relationship between changes in cardiovascular disease risk factors and progression to hypertension in prehypertensive
men at baseline
CVD, cardiovascular disease; HTN, hypertension; NS, never or former smoker; CS, current smoker; NDR, non-drinker; DR, current drinker; RE, those tak-
ing regular exercise; NRE, those not taking regular exercise; NBMI, those with a BMI<25.0 kg/m2; OBMI, those with a BMI ≥25.0 kg/m2; NFSG, those with
a FSG <100 mg/dL; HFSG, those with a FSG ≥126 mg/dL; NTC, those with a TC<240 mg/dL; HTC, those with a TC ≥240 mg/dL.
*p-value by log-rank test.
Health behavioral factors
Smoking habit change
CS at baseline and follow-up 4,996 2,471 (49.5) 2,525 <0.0001
CS at baseline, NS at follow-up 2,261 970 (42.9) 1,291
NS at baseline, CS at follow-up 490 250 (51.0) 240
NS at baseline and follow-up 4,540 2,138 (47.1) 2,402
Alcohol drinking habit change
DR at baseline and follow-up 8,204 4,176 (50.9) 4,028 <0.0001
DR at baseline, ND at follow-up 1,516 569 (37.5) 947
ND at baseline, DR at follow-up 430 168 (39.1) 262
ND at baseline and follow-up 1,993 886 (44.5) 1,107
Regular exercise habit change
NRE at baseline and follow-up 7,206 3,575 (49.6) 3,631 <0.0001
NRE at baseline, RE at follow-up 1,570 590 (37.6) 980
RE at baseline, NRE at follow-up 2,190 1,079 (49.3) 1,111
RE at baseline and follow-up 1,303 578 (44.4) 725
Comorbidity
Body mass index level change
OBMI at baseline and follow-up 2,703 1,573 (58.2) 1,130 <0.0001
OBMI at baseline, NBMI at follow-up 369 166 (45.0) 203
NBMI at baseline, OBMI at follow-up 1,690 834 (49.3) 856
NBMI at baseline and follow-up 8,139 3,576 (43.9) 4,563
Fasting serum glucose level change
HFSG at baseline and follow-up 162 83 (51.2) 79 0.0071
HFSG at baseline, NFSG at follow-up 103 57 (55.3) 46
NFSG at baseline, HFSG at follow-up 541 282 (52.1) 259
NFSG at baseline and follow-up 12,093 5,726 (47.3) 6,367
Serum total cholesterol level change
HTC at baseline and follow-up 412 231 (56.1) 181 <0.0001
HTC at baseline, NTC at follow-up 364 178 (48.9) 186
NTC at baseline, HTC at follow-up 1,122 596 (53.1) 526
NTC at baseline and follow-up 11,010 5,148 (46.8) 5,862
group stood at 36.2% and the non-drinking group at baseline
and drinking group at follow-up at 31.7%. The group that
changed from non-exercise to exercise showed the lowest pro-
gression rate (22.6%). In terms of FSG measurements, the
continuously normal FSG group showed the lowest progres-
sion rate (34.9%), and the continuously high FSG group show-
ed the highest progression rate (86.7%). With regards TC
measurements, the group with improvements in TC (42.3%)
had a lower progression rate than the consistently HTC group
(48.4%) (Table 3).
The HRs of progression to HTN are shown by age, family
history of CVD, changes in health behavior factors (smoking,
alcohol drinking, regular exercise), and changes in comorbidi-
ties (BMI, FSG, TC) in prehypertensive subjects at baseline
(Table 4). With advanced age, the progression to HTN was
accelerated. In addition, compared to the group without a fami-
ly history of CVD, men with such a background showed about
a 1.146 times higher risk of contracting HTN. Improvements
in CVD risk factors were also closely associated with a dec-
reased risk of progression to HTN. Improvements in health
behaviors and co-morbidities significantly diminished the risk
of HTN from 1.269 to 1.531 times in men. In women, smok-
ing was excluded from analyses due to the extremely small
size of the sample. Unlike in men, subjects taking regular exer-
cise reduced their probability of HTN by 1.873 times (95%
CI: 0.426-0.669).
DISCUSSION
To our knowledge, this is the first investigation of the rela-
tionship between changes in CVD risk factors and the rate of
5
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Total no.Changes in CVD risk factors No. of HTN (%) No. of censored p-value*
Table 3. Relationship between changes in cardiovascular disease risk factors and progression to hypertension in prehypertensive
women at baseline
CVD, cardiovascular disease; HTN, hypertension; NDR, non-drinker; DR, current drinker; RE, those taking regular exercise; NRE, those not taking regular
exercise; NBMI, those with a BMI <25.0 kg/m2; OBMI, those with a BMI ≥25.0 kg/m2; NFSG, those with a FSG<100 mg/dL; HFSG, those with a FSG ≥126
mg/dL; NTC, those with a TC<240 mg/dl; HTC, those with a TC ≥240 mg/dL.
*p-value by log-rank test.
Health behavioral factors
Alcohol drinking habit change
DR at baseline and follow-up 269 104 (38.7) 165 0.2873
DR at baseline, ND at follow-up 271 98 (36.2) 173
ND at baseline, DR at follow-up 180 57 (31.7) 123
ND at baseline and follow-up 2,220 784 (35.3) 1,436
Regular exercise habit change
NRE at baseline and follow-up 2,293 827 (36.1) 1,466 <0.0001
NRE at baseline, RE at follow-up 425 96 (22.6) 329
RE at baseline, NRE at follow-up 308 122 (39.6) 186
RE at baseline and follow-up 144 55 (38.2) 89
Comorbidity
Body mass index level change
OBMI at baseline and follow-up 304 168 (55.3) 136 <0.0001
OBMI at baseline, NBMI at follow-up 69 27 (39.1) 42
NBMI at baseline, OBMI at follow-up 297 138 (46.5) 159
NBMI at baseline and follow-up 2,720 863 (31.7) 1,857
Fasting serum glucose level change
HFSG at baseline and follow-up 15 13 (86.7) 2 <0.0001
HFSG at baseline, NFSG at follow-up 14 6 (42.9) 8
NFSG at baseline, HFSG at follow-up 50 20 (40.0) 30
NFSG at baseline and follow-up 3,312 1,157 (34.9) 2,155
Serum total cholesterol level change
HTC at baseline and follow-up 91 44 (48.4) 47 0.0003
HTC at baseline, NTC at follow-up 52 22 (42.3) 30
NTC at baseline, HTC at follow-up 366 151 (41.3) 215
NTC at baseline and follow-up 2,882 979 (34.0) 1,903
6progression of HTN using national longitudinal data in Korea.
These longitudinal data showed that improvements in CVD
risk factors diminished the rate of progression of HTN in pre-
hypertensive men and women. The periodic screening of BP
in adults has been recommended to detect the onset of HTN
[3, 16] so that appropriate measures can be taken to prevent
the morbidity and mortality associated with raised BP [17].
The European Task Force on Prevention of Coronary Disease
recommended a follow-up interval of up to 5 yr [18]. Current
recommendations for follow-up BP screening of individuals
without HTN are empirical rather than evidence-based, and
vary widely [16, 18]. 
It has previously been reported that older age, higher BMI,
and elevated baseline BP are independent risk factors for future
Epidemiology and Health 2010;32:e2010003
Men
HR 95% CI
Women
HR 95% CI
Table 4. Risk factors for progression to hypertension in prehypertensive group at baseline
All covariates were included in the model. HR, hazard ratio; CI, confidence interval; CVD, cardiovascular disease; HTN, hypertension; NA, not available;
NS, never or former smoker; CS, current smoker; NDR, non-drinker; DR, current drinker; RE, those taking regular exercise; NRE, those not taking regular
exercise; NBMI, those with a BMI <25.0 kg/m2; OBMI, those with a BMI ≥25.0 kg/m2; NFSG, those with a FSG <100 mg/dL; HFSG, those with a FSG ≥126
mg/dL; NTC, those with a TC <240 mg/dL; HTC, those with a TC ≥240 mg/dL.
Age 1.026 1.022-1.031 1.034 1.022-1.046
Family history of CVD 
No 1.000 1.000
Yes 1.146 1.059-1.240 1.145 0.980-1.337
Health behavioral factors
Smoking habit change
CS at baseline and follow-up 1.000
CS at baseline, NS at follow-up 0.756 0.696-0.821 NA NA
NS at baseline, CS at follow-up 0.996 0.864-1.149 NA NA
NS at baseline and follow-up 0.917 0.859-0.978 NA NA
Drinking habit change
DR at baseline and follow-up 1.000 1.000
DR at baseline, ND at follow-up 0.669 0.607-0.738 0.829 0.613-1.121
ND at baseline, DR at follow-up 0.676 0.571-0.800 0.745 0.525-1.055
ND at baseline and follow-up 0.811 0.749-0.879 0.849 0.682-1.057
Regular exercise habit change
NRE at baseline and follow-up 1.000 1.000
NRE at baseline, RE at follow-up 0.653 0.593-0.718 0.534 0.426-0.669
RE at baseline, NRE at follow-up 0.997 0.925-1.076 1.053 0.851-1.303
RE at baseline and follow-up 0.808 0.735-0.889 0.997 0.740-1.343
Comorbidity
BMI level change
OBMI at baseline and follow-up 1.000 1.000
OBMI at baseline, NBMI at follow-up 0.715 0.593-0.861 0.634 0.401-1.001
NBMI at baseline, OBMI at follow-up 0.752 0.684-0.827 0.764 0.585-0.997
NBMI at baseline and follow-up 0.693 0.648-0.742 0.580 0.476-0.706
Fasting serumglucose level change
HFSG at baseline and follow-up 1.000 1.000
HFSG at baseline, NFSG at follow-up 1.073 0.732-1.573 0.542 0.179-1.639
NFSG at baseline, HFSG at follow-up 0.811 0.611-1.076 0.254 0.110-0.587
NFSG at baseline and follow-up 0.862 0.670-1.109 0.264 0.134-0.519
Serum total cholesterol level change
HTC at baseline and follow-up 1.000 1.000
HTC at baseline, NTC at follow-up 0.788 0.635-0.977 1.319 0.707-2.463
NTC at baseline, HTC at follow-up 0.838 0.707-0.993 0.807 0.528-1.234
NTC at baseline and follow-up 0.789 0.682-0.914 0.806 0.544-1.193
HTN [3, 19, 20]. Recent reports from the Framingham Heart
Study suggested that persons with normal BP at 55 years of
age had a 90% lifetime risk of developing HTN [3, 21]. An
increasing incidence of HTN with increasing age was found,
which was in line with other results [11, 22]. Cigarette smok-
ing is well established as a causal factor in coronary heart dis-
ease and stroke. According to the Korea Medical Insurance
Corporation (KMIC) study, smoking is also a major indepen-
dent risk factor for ischemic heart disease (IHD), CVD, and
atherosclerotic cardiovascular disease (ASCVD). The RR from
current smoking was reported to be 3.3 (95% CI: 1.7-6.2) for
IHD and 1.6 (95% CI: 1.2-2.3) for CVD [23]. In the Cox pro-
portional hazard model, the HR (95% CI) of ex-smokers was
0.756 (0.696-0.821) in men, compared with continuous smok-
ers among the current smokers at baseline. Heavy alcohol
consumption may cause other cardiac disorders and is associ-
ated with an increased risk of stroke [24]. The HR (95% CI)
of non-drinkers was 0.669 (0.607-0.738) in men and 0.829
(0.613-1.121) in women, respectively, compared with contin-
uous drinkers. In general, regular exercise reduces the risk of
coronary artery disesase (CHD). Regular exercise has BP-
lowering effects [25]. It was reported that individuals partic-
ipating in 20 min of light or moderate regular exercise every
day had about a 30% lower risk of death from CHD than
sedentary individuals [26]. In this study, in those not taking
regular exercise at baseline, the HR (95% CI) of subjects
who later started regular exercise was 0.653 (0.593-0.718) in
men and 0.534 (0.426-0.669) in women, compared with those
not participating in regular exercise at all. Obesity contributes
to elevated BP [17]. It has consistently been proven through
clinical trials that reducing weight can lower SBP and DBP
[27]. The risk of HTN is higher among obese people (BMI ≥
25 kg/m2). The BMI is significantly and positively correlated
with both SBP and DBP [28]. Jee et al. [15] found that under-
weight, overweight and obese men and women had higher
rates of death than normal weight men and women. Several
previous studies have reported that weight loss might play a
protective role in the progression to HTN [9, 29, 30]. In this
study, the HR (95% CI) of the weight loss group (BMI <25
kg/m2) was 0.715 (0.593-0.861) in men and 0.634 (0.401-
1.001) in women, compared with the continuously obese
group (BMI ≥25 kg/m2). Kim et al. [11] reported that dia-
betes mellitus (DM) was an independent risk factor for HTN
in women, but not men. In this study, the baseline FSG level
was associated with the progression of HTN in both men and
women. However, lowering the FSG did not play a protec-
tive role in the progression to HTN in either men or women.
In previous studies, a higher TC was a predictor of progres-
sion to HTN [30]. In another study, the direct and progres-
sive relationship between TC and CVD was reported [31]. In
this study, TC was a strong predictor of the progression to
HTN. Compared to the consistently high TC group (TC ≥
240 mg/dL), the ‘back to normal’ TC group (TC <240 mg/dL)
lowered their risk by 1.27 times in men, controlling for other
CVD risk factors. 
This study has several potential limitations. First, there was
no information on antihypertensive medications in this popu-
lation, which could be a confounding factor in the association
between the CVD risk factors and BP. The absence of medi-
cation information could have resulted in a conservative esti-
mate of the incidence of PreHTN and HTN. Second, misclassi-
fication bias could have arisen from measurement error because
the biennial health examinations were carried out at various
hospitals throughout the country and the laboratory techniques
varied. However, the data collected were subject to internal
and external quality control [32, 33]. Third, we categorized
the individuals based on the average BP in 1994 and 1995
obtained from a single BP measurement, as in the recent study
by Hansen et al. [34], while other studies used two readings
[2]. Lastly, since we used data from biennial BP measurements,
we had no information on possible changes during the inter-
vening period. It is possible that individuals with HTN changed
their unhealthy lifestyles. For example, when a current smoker
was diagnosed with PreHTN at the first examination, she/he
may have subsequently quit smoking. After stopping smok-
ing, BP could have returned to normal. We are not in a posi-
tion to know whether smoking cessation alone contributed to
decreasing BP.
Despite several limitations, this study has a few strengths,
including the extensive coverage of South Koreans with re-
peated measures of BP, FSG, TC, weight, and height through
the KCPS data. This large sample size and the prospective
design had sufficient statistical power in general, even in sub-
group and dose-response analyses [23, 35]. 
In conclusion, this study confirmed the findings of previous
studies demonstrating a relationship between changes in CVD
risk factors and the progression from PreHTN to HTN. With
regards public health implications in Korea, the prehyperten-
sive population should be targeted for specific health interven-
tion to change their unhealthy lifestyles. Large intervention
studies should be established urgently in order to confirm the
results of this study.
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